Across TCGA pan-cancer cohorts, LINC01359 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated LINC01359 data layer.
The strongest signal is observed in mesothelioma (MESO), where higher LINC01359 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC01359 expression acts as an unfavorable survival marker, although some lineages such as MESO and BLCA show a favorable association.
MESO, BLCA, and BRCA are the cancer types where LINC01359 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.